DK3302499T3 - Behandling af mitokondrielle sygdomme - Google Patents

Behandling af mitokondrielle sygdomme Download PDF

Info

Publication number
DK3302499T3
DK3302499T3 DK16728892.7T DK16728892T DK3302499T3 DK 3302499 T3 DK3302499 T3 DK 3302499T3 DK 16728892 T DK16728892 T DK 16728892T DK 3302499 T3 DK3302499 T3 DK 3302499T3
Authority
DK
Denmark
Prior art keywords
treatment
mitochondrial diseases
mitochondrial
diseases
Prior art date
Application number
DK16728892.7T
Other languages
English (en)
Inventor
Seves Ramon Martí
Vioque Emiliano González
Bermejo Cora Blázquez
Torronteras Javier Torres
Pérez Raquel Cabrera
Navarro Yolanda Cámara
Original Assignee
Fundacio Hospital Univ Vall D Hebron Institut De Recerca
Centro De Investig Biomedica En Red Ciber
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundacio Hospital Univ Vall D Hebron Institut De Recerca, Centro De Investig Biomedica En Red Ciber filed Critical Fundacio Hospital Univ Vall D Hebron Institut De Recerca
Application granted granted Critical
Publication of DK3302499T3 publication Critical patent/DK3302499T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C1/00—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK16728892.7T 2015-06-05 2016-06-03 Behandling af mitokondrielle sygdomme DK3302499T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15170825 2015-06-05
PCT/EP2016/062636 WO2016193421A1 (en) 2015-06-05 2016-06-03 Treatment of mitochondrial diseases

Publications (1)

Publication Number Publication Date
DK3302499T3 true DK3302499T3 (da) 2023-04-03

Family

ID=53298228

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16728892.7T DK3302499T3 (da) 2015-06-05 2016-06-03 Behandling af mitokondrielle sygdomme

Country Status (22)

Country Link
US (3) US11337980B2 (da)
EP (2) EP3302499B1 (da)
JP (4) JP6885544B2 (da)
CN (2) CN107820430A (da)
AU (2) AU2016273340B2 (da)
BR (1) BR112017025839A2 (da)
CA (1) CA2991271C (da)
CY (1) CY1126058T1 (da)
DK (1) DK3302499T3 (da)
ES (1) ES2944551T3 (da)
FI (1) FI3302499T3 (da)
HR (1) HRP20230277T1 (da)
HU (1) HUE062134T2 (da)
IL (3) IL320960A (da)
LT (1) LT3302499T (da)
MX (2) MX2017015566A (da)
PL (1) PL3302499T3 (da)
PT (1) PT3302499T (da)
RS (1) RS64273B1 (da)
RU (1) RU2745611C2 (da)
SI (1) SI3302499T1 (da)
WO (1) WO2016193421A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112017025839A2 (en) * 2015-06-05 2018-08-14 Fundació Hospital Universitari Vall D'hebron - Institut De Recerca treatment of mitochondrial diseases
JP6599484B2 (ja) 2015-06-17 2019-10-30 ザ・トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク ミトコンドリアｄｎａ枯渇症候群を含む不均衡なヌクレオチドプールによって引き起こされる疾患のためのデオキシヌクレオシド療法
EP4313068A4 (en) 2021-03-26 2024-12-25 UCB Biosciences, Inc. Aqueous solutions containing purines and pyrimidines and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5246708A (en) 1987-10-28 1993-09-21 Pro-Neuron, Inc. Methods for promoting wound healing with deoxyribonucleosides
ZA892928B (en) * 1988-04-25 1991-01-30 Pro Neuron Inc Pharmaceutical compositions containing deoxyribonucleosides for wound healing
IT1247510B (it) 1991-04-19 1994-12-17 Univ Cagliari Composizioni terapeutiche ad attivita' anti-hiv costituite da 2',3'-didesossiadenosina e sostanze inibitrici della adenosina-deaminasi
JPH0635389A (ja) 1992-07-20 1994-02-10 Fujitsu Ltd ホログラム記録材料
US20020006913A1 (en) * 1997-11-04 2002-01-17 Von Borstel Reid W. Antimutagenic compositions for treatment and prevention of photodamage to skin
US6472378B2 (en) * 1998-08-31 2002-10-29 Pro-Neuron, Inc. Compositions and methods for treatment of mitochondrial diseases
IL144964A0 (en) * 1999-02-23 2002-06-30 Pro Neuron Inc Methods of treatment of mitochondrial disorders
PL2424495T3 (pl) * 2009-04-28 2018-06-29 Bioelectron Technology Corporation Leczenie dziedzicznej neuropatii nerwów wzrokowych lebera i dominującego zaniku nerwu wzrokowego chinonami tokotrienolu
US20150065556A1 (en) * 2013-08-05 2015-03-05 Whitehead Institute For Biomedical Research Therapeutic targets for mitochondrial disorders
CN104524546B (zh) 2014-12-18 2019-06-21 中国科学院广州生物医药与健康研究院 用于治疗Alpers-Huttenlocher综合征的药物组合物
BR112017025839A2 (en) * 2015-06-05 2018-08-14 Fundació Hospital Universitari Vall D'hebron - Institut De Recerca treatment of mitochondrial diseases

Also Published As

Publication number Publication date
CA2991271C (en) 2023-10-17
JP6885544B2 (ja) 2021-06-16
HUE062134T2 (hu) 2023-09-28
FI3302499T3 (fi) 2023-05-04
WO2016193421A1 (en) 2016-12-08
PL3302499T3 (pl) 2023-07-24
EP4218938A1 (en) 2023-08-02
SI3302499T1 (sl) 2023-08-31
AU2021282462A1 (en) 2022-01-06
MX2017015566A (es) 2018-08-15
AU2016273340A1 (en) 2018-01-25
MX2022012719A (es) 2022-11-07
IL255988A (en) 2018-04-30
JP2025172733A (ja) 2025-11-26
CN119386033A (zh) 2025-02-07
CN107820430A (zh) 2018-03-20
HRP20230277T1 (hr) 2023-06-23
AU2016273340B2 (en) 2021-09-09
CA2991271A1 (en) 2016-12-08
CY1126058T1 (el) 2023-11-15
JP2018516923A (ja) 2018-06-28
RU2745611C2 (ru) 2021-03-29
JP2023123444A (ja) 2023-09-05
RU2018123532A (ru) 2019-12-30
PT3302499T (pt) 2023-05-12
US20180161332A1 (en) 2018-06-14
EP3302499B1 (en) 2023-03-15
RS64273B1 (sr) 2023-07-31
IL289747A (en) 2022-03-01
AU2021282462B2 (en) 2023-10-05
US20230060544A1 (en) 2023-03-02
US11998551B2 (en) 2024-06-04
IL289747B2 (en) 2025-10-01
US20250099473A1 (en) 2025-03-27
EP3302499A1 (en) 2018-04-11
IL289747B1 (en) 2025-06-01
ES2944551T3 (es) 2023-06-22
LT3302499T (lt) 2023-05-25
US11337980B2 (en) 2022-05-24
BR112017025839A2 (en) 2018-08-14
IL320960A (en) 2025-07-01
RU2018123532A3 (da) 2019-12-30
IL255988B (en) 2022-02-01
JP2021121594A (ja) 2021-08-26

Similar Documents

Publication Publication Date Title
DK3851537T5 (da) Behandling af hyperbilirubinæmi
IL263680A (en) Combination therapies
PL3283527T3 (pl) Leczenie skojarzone nowotworów
DK3212233T3 (da) Kombinationsterapi til behandling af sygdom
HUE047477T2 (hu) Palbociclib szilárd dózisformái
DK3777855T3 (da) Fremgangsmåder til behandling af fibrotiske sygdomme
DK3125875T3 (da) Inhalerbar rapamycinformulering til behandling af aldersrelaterede tilstande
DK3240612T3 (da) Fremgangsmåder til behandling af nethindesygdomme
DK3244948T3 (da) Bestemmelse af medikamentdosis
HUE056287T2 (hu) Pancreatitis kezelése
DK3169328T3 (da) Quinolinderivater til behandling af inflammationssygdomme
DK3390390T3 (da) Bipyrazolylderivater egnede til behandling af autoimmunsygdomme
DK3458052T3 (da) Kombinationsbehandling af cancer
DK3548061T3 (da) Behandling af neurologiske sygdomme
IL263050B (en) Derivatives of sobetirome
EP3406336A4 (en) NANO FOIL OF CORE CASE STRUCTURE TYPE
EP3360010A4 (en) BI PHOTONS WITH VOTABLE SOURCE
EP3375108A4 (en) SELECTIVE WIFI
DK3283210T3 (da) Fremgangsmåde
DK3307267T3 (da) Behandling af multipel sklerose
LT3119384T (lt) Intrahepatinių cholestazinių ligų gydymas
DK3237621T3 (da) Varianter af human alpha-galactosidase
IL257764B (en) Methods for treatment of diseases
DK3297619T3 (da) Terapeutiske anvendelser af L-4-chlorkynurenin
DK3368044T3 (da) Behandling af hepatisk steatose-relateret oligo-ovulation